enGene Therapeutics Inc. (ENGN) stock
ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
$1.72−0.17 (-8.99%)
Close on Nov 17, 2026Market cap $115.27MP/E –Yield 0.00%
enGene Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
enGene Therapeutics's price to book ratio was 0.5× on Nov 11, 2026, against 2.1× a year earlier. Over the last 3 years it ranged from 0.4× to 6.3×, with a median of 1.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | −2.3 |
| 2025 | Dec 31, 2025 | 2.8× | +1.6 |
| 2024 | Dec 31, 2024 | 1.2× | −1.7 |
| 2023 | Dec 29, 2023 | 3.0× | – |
See a number that looks wrong?